Cargando…

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization

Heart failure (HF) is a highly prevalent disorder for which disease mechanisms are incompletely understood. The discovery of disease-associated proteins with causal genetic evidence provides an opportunity to identify new therapeutic targets. METHODS: We investigated the observational and causal ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henry, Albert, Gordillo-Marañón, María, Finan, Chris, Schmidt, Amand F., Ferreira, João Pedro, Karra, Ravi, Sundström, Johan, Lind, Lars, Ärnlöv, Johan, Zannad, Faiez, Mälarstig, Anders, Hingorani, Aroon D., Lumbers, R. Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010023/ https://www.ncbi.nlm.nih.gov/pubmed/35300523 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.056663

Ejemplares similares

Genetic drug target validation using Mendelian randomisation
por: Schmidt, Amand F., et al.
Publicado: (2020)

Lipid lowering and Alzheimer disease risk: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2019)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Lind, Lars, et al.
Publicado: (2021)

Plasma Protein Profile of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure in 2 Cohorts
por: Lind, Lars, et al.
Publicado: (2021)

Proteins associated with incident metabolic syndrome in population-based cohorts
por: Lind, Lars, et al.
Publicado: (2021)

In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional study
por: Beijer, Kristina, et al.
Publicado: (2019)

Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
por: Almramhi, Mona M., et al.
Publicado: (2023)

Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged Men
por: Ärnlöv, Johan, et al.
Publicado: (2011)

Impact of Aging on the Strength of Cardiovascular Risk Factors: A Longitudinal Study Over 40 Years
por: Lind, Lars, et al.
Publicado: (2018)

Longitudinal effects of aging on plasma proteins levels in older adults – associations with kidney function and hemoglobin levels
por: Lind, Lars, et al.
Publicado: (2019)

Proteomic Analysis of Longitudinal Changes in Blood Pressure
por: Lin, Yi-Ting, et al.
Publicado: (2019)

A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases
por: Lind, Lars, et al.
Publicado: (2021)

Large‐Scale Metabolomics and the Incidence of Cardiovascular Disease
por: Lind, Lars, et al.
Publicado: (2023)

No Clinically Relevant Effect of Heart Rate Increase and Heart Rate Recovery During Exercise on Cardiovascular Disease: A Mendelian Randomization Analysis
por: Mensah-Kane, Josephine, et al.
Publicado: (2021)

Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study
por: Hansson, Jonas, et al.
Publicado: (2011)

The association between glomerular filtration rate and left ventricular function in two independent community-based cohorts of elderly
por: Nerpin, Elisabet, et al.
Publicado: (2014)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

A Mendelian randomization study of the effects of blood lipids on breast cancer risk
por: Nowak, Christoph, et al.
Publicado: (2018)

Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases
por: Howe, Laurence J, et al.
Publicado: (2020)

Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach
por: Carlsson, Axel C., et al.
Publicado: (2019)

Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
por: Sae-jie, Wichanon, et al.
Publicado: (2023)

Serum Cathepsin S Is Associated With Decreased Insulin Sensitivity and the Development of Type 2 Diabetes in a Community-Based Cohort of Elderly Men
por: Jobs, Elisabeth, et al.
Publicado: (2013)

Multicohort Metabolomics Analysis Discloses 9‐Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation
por: Lind, Lars, et al.
Publicado: (2021)

The metabolomic profile associated with clustering of cardiovascular risk factors—A multi-sample evaluation
por: Lind, Lars, et al.
Publicado: (2022)

Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
por: Schmidt, Amand F., et al.
Publicado: (2023)

Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
por: Nowak, Christoph, et al.
Publicado: (2018)

Genetically Predicted Circulating Copper and Risk of Chronic Kidney Disease: A Mendelian Randomization Study
por: Ahmad, Shafqat, et al.
Publicado: (2022)

The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: a Mendelian randomization study
por: Borges, Maria-Carolina, et al.
Publicado: (2022)

Strong Associations between Plasma Osteopontin and Several Inflammatory Chemokines, Cytokines, and Growth Factors
por: Larsson, Anders, et al.
Publicado: (2021)

Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D
por: Berry, Diane J., et al.
Publicado: (2012)

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
por: Gordillo-Marañón, María, et al.
Publicado: (2021)

Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study
por: Nowak, Christoph, et al.
Publicado: (2016)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Correction: Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study
por: Nowak, Christoph, et al.
Publicado: (2017)

Left ventricular geometric patterns and adaptations to hemodynamics are similar in elderly men and women
por: Masiha, Said, et al.
Publicado: (2011)

Non-targeted urine metabolomics and associations with prevalent and incident type 2 diabetes
por: Salihovic, Samira, et al.
Publicado: (2020)

LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
por: Gratton, Jasmine, et al.
Publicado: (2022)

Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort
por: Nerpin, Elisabet, et al.
Publicado: (2008)

Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis
por: Schmidt, Amand, et al.
Publicado: (2023)

Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes
por: Vavruch, Camilla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1477n1joo9qheucmj0l0i7481q